Acetylcholine receptor antibodies
(AchR antibodies)
Material: | 1 ml serum |
Methods: | Ligandenassays → Radioimmunoassay (RIA) | Reference range | < 0,4 nmol/l – 0,5 nmol/l |
Indication | Suspicion of generalized or ocular myasthenia gravis |
Please note | 85 % of patients with generalized form of myasthenia gravis have AchR-antibodies. These bind to the nicotinic acetylcholine receptor of the neuromuscular end plate and not only hinder the ligand binding, but also lead to an internalization of the receptors and possibly to immune-mediated destruction of the end plate, which decreases the responsiveness of musculature and leads to exercise dependent muscle weakness. Patients with the ocular form of MG are more often seronegative. Children of mothers with active MG show a transient form of neonatal MG. Intra individually the determination of antibodies is also suitable for monitoring of disease-activity, as the serum concentration shows good correlation with the intensity of the muscle weakness. Further autoantibodies: Anti-titin. Anti-titin positive patients more often have thymomas than patients who are only AchR-antibody positive. Differential diagnosis: Lambert Eaton syndrome and neurogenic myotonia, please also refer to VGCC-antibodies and VGKC-antibodies, antineural antibodies. |
Accredited | ja |
More Results for the letter A
- Angina Plaut-Vincenti (APV)
- Treponema vincentii and fusobacterium nucleatum
- ANP (ANP)
- atrial natriuretic peptide
- Anti-actin autoantibodies (ACTIN)
- Anti-alpha fodrin autoantibodies (AFODG)
- Anti-desmoglein 1/3 (DESMO)
- Anti-DNA antibodies (DNADS)
- ds-DNA antibodies (double-stranded)
- Anti-epidermal basal membrane (EPI)
- Anti-goblet cell autoantibodies (BECZE)
- Anti-mitochondrial antibodies (AMA)
- AMA and AMA subtype 2
- Anti-mullarian hormone (AMH)
- Anti-sickle cell desmosomes (STADE)
- Anti-SP100 (SP100)
- multiple nuclear dots
- Antibiogram (ANTIBIO)
- Antibodies against α-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid receptor (AMPAR)
- Antibodies against adenylate kinase 5 (Ak5)
- Ak5
- Antibodies against contactin-associated protein 2 (CASPR2)
- Antibodies against ganglionic (alpha-3) acetylcholine receptors (gAChR)
- (gAChR)
- Antibodies against glutamate decarboxylase 65 kDa (GAD65)
- Antibodies against leucine-rich glioma inactivated protein 1 (LGI1)
- Antibodies against LRP4
- (low-density lipoprotein receptor-related protein 4)
- Antibodies against myelin oligodendrocyte glycoprotein (MOG)
- Antibodies against N-methyl-D-aspartate receptor receptors (NMDAR)
- Antibodies against oxidized LDL (LDLOX)
- Antibodies against the γ-aminobutyric acid A receptor (GABA-A-R)
- Antibodies against the γ-aminobutyric acid B receptor (GABA-B-R)
- Antibodies against the glial fibrillary acidic protein (GFAP)
- Antibodies against the glycine receptor (GlyR)
- Antibodies against the metabotropic glutamate receptor type 1 (mGluR1 antibodies)
- Antibody screen (ANTI01)
- Antibody screening (AK)
- AKS